189 related articles for article (PubMed ID: 16732286)
41. Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2.
Issa E; Moss AJ; Fischer M; Kang M; Ahmed S; Farah H; Bate N; Giakomidi D; Brindle NP
Mol Pharm; 2018 Sep; 15(9):3962-3968. PubMed ID: 30036484
[TBL] [Abstract][Full Text] [Related]
42. C4-dicarboxylates sensing mechanism revealed by the crystal structures of DctB sensor domain.
Zhou YF; Nan B; Nan J; Ma Q; Panjikar S; Liang YH; Wang Y; Su XD
J Mol Biol; 2008 Oct; 383(1):49-61. PubMed ID: 18725229
[TBL] [Abstract][Full Text] [Related]
43. X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding.
Yamada M; Ohsawa K; Imai Y; Kohsaka S; Kamitori S
J Mol Biol; 2006 Dec; 364(3):449-57. PubMed ID: 17011575
[TBL] [Abstract][Full Text] [Related]
44. Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation.
Wehrle C; Van Slyke P; Dumont DJ
Biochem J; 2009 Oct; 423(3):375-80. PubMed ID: 19689429
[TBL] [Abstract][Full Text] [Related]
45. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
Sondermann P; Kaiser J; Jacob U
J Mol Biol; 2001 Jun; 309(3):737-49. PubMed ID: 11397093
[TBL] [Abstract][Full Text] [Related]
47. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
48. Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.
Hodous BL; Geuns-Meyer SD; Hughes PE; Albrecht BK; Bellon S; Bready J; Caenepeel S; Cee VJ; Chaffee SC; Coxon A; Emery M; Fretland J; Gallant P; Gu Y; Hoffman D; Johnson RE; Kendall R; Kim JL; Long AM; Morrison M; Olivieri PR; Patel VF; Polverino A; Rose P; Tempest P; Wang L; Whittington DA; Zhao H
J Med Chem; 2007 Feb; 50(4):611-26. PubMed ID: 17253678
[TBL] [Abstract][Full Text] [Related]
49. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats.
Fiedler U; Krissl T; Koidl S; Weiss C; Koblizek T; Deutsch U; Martiny-Baron G; Marmé D; Augustin HG
J Biol Chem; 2003 Jan; 278(3):1721-7. PubMed ID: 12427764
[TBL] [Abstract][Full Text] [Related]
50. Residue-level determinants of angiopoietin-2 interactions with its receptor Tie2.
Bakhman A; Rabinovich E; Shlamkovich T; Papo N; Kosloff M
Proteins; 2019 Mar; 87(3):185-197. PubMed ID: 30520519
[TBL] [Abstract][Full Text] [Related]
51. Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme.
Aritomi M; Kunishima N; Okamoto T; Kuroki R; Ota Y; Morikawa K
Nature; 1999 Oct; 401(6754):713-7. PubMed ID: 10537111
[TBL] [Abstract][Full Text] [Related]
52. Protein tyrosine kinase-substrate interactions.
Bose R; Holbert MA; Pickin KA; Cole PA
Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
[TBL] [Abstract][Full Text] [Related]
53. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.
Mace PD; Cutfield JF; Cutfield SM
Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948
[TBL] [Abstract][Full Text] [Related]
54. Circulating angiopoietin-2 and its soluble receptor Tie-2 concentrations are related to inflammatory markers in the general population.
Schuldt EA; Lieb W; Dörr M; Lerch MM; Völzke H; Nauck M; Friedrich N
Cytokine; 2018 May; 105():1-7. PubMed ID: 29427772
[TBL] [Abstract][Full Text] [Related]
55. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
Chatwell L; Holla A; Kaufer BB; Skerra A
Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
[TBL] [Abstract][Full Text] [Related]
56. The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1.
Márquez JA; Galfré E; Dupeux F; Flot D; Moran O; Dimasi N
J Mol Biol; 2007 Mar; 367(2):310-8. PubMed ID: 17275839
[TBL] [Abstract][Full Text] [Related]
57. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K
FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616
[TBL] [Abstract][Full Text] [Related]
58. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
[TBL] [Abstract][Full Text] [Related]
59. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity.
Procopio WN; Pelavin PI; Lee WM; Yeilding NM
J Biol Chem; 1999 Oct; 274(42):30196-201. PubMed ID: 10514510
[TBL] [Abstract][Full Text] [Related]
60. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
